121 related articles for article (PubMed ID: 24840069)
21. Tyrosinemia type I and not treatment with NTBC causes slower learning and altered behavior in mice.
Hillgartner MA; Coker SB; Koenig AE; Moore ME; Barnby E; MacGregor GG
J Inherit Metab Dis; 2016 Sep; 39(5):673-682. PubMed ID: 27271696
[TBL] [Abstract][Full Text] [Related]
22. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I.
Overturf K; Al-Dhalimy M; Tanguay R; Brantly M; Ou CN; Finegold M; Grompe M
Nat Genet; 1996 Mar; 12(3):266-73. PubMed ID: 8589717
[TBL] [Abstract][Full Text] [Related]
23. Extensive changes in liver gene expression induced by hereditary tyrosinemia type I are not normalized by treatment with 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC).
Luijerink MC; Jacobs SM; van Beurden EA; Koornneef LP; Klomp LW; Berger R; van den Berg IE
J Hepatol; 2003 Dec; 39(6):901-9. PubMed ID: 14642604
[TBL] [Abstract][Full Text] [Related]
24. Activation of nuclear factor E2-related factor 2 in hereditary tyrosinemia type 1 and its role in survival and tumor development.
Marhenke S; Lamlé J; Buitrago-Molina LE; Cañón JM; Geffers R; Finegold M; Sporn M; Yamamoto M; Manns MP; Grompe M; Vogel A
Hepatology; 2008 Aug; 48(2):487-96. PubMed ID: 18666252
[TBL] [Abstract][Full Text] [Related]
25. Xeno-repopulation of Fah -/- Nod/Scid mice livers by human hepatocytes.
Su B; Liu C; Xiang D; Zhang H; Yuan S; Wang M; Chen F; Zhu H; He Z; Wang X; Hu Y
Sci China Life Sci; 2011 Mar; 54(3):227-34. PubMed ID: 21416322
[TBL] [Abstract][Full Text] [Related]
26. Studying HBV Infection and Therapy in Immune-Deficient NOD-Rag1-/-IL2RgammaC-null (NRG) Fumarylacetoacetate Hydrolase (Fah) Knockout Mice Transplanted with Human Hepatocytes.
Li F; Nio K; Yasui F; Murphy CM; Su L
Methods Mol Biol; 2017; 1540():267-276. PubMed ID: 27975325
[TBL] [Abstract][Full Text] [Related]
27. Rescue from neonatal death in the murine model of hereditary tyrosinemia by glutathione monoethylester and vitamin C treatment.
Langlois C; Jorquera R; Orejuela D; Bergeron A; Finegold MJ; Rhead WJ; Tanguay RM
Mol Genet Metab; 2008 Mar; 93(3):306-13. PubMed ID: 18023223
[TBL] [Abstract][Full Text] [Related]
28. Senescence suppressed proliferation of host hepatocytes is precondition for liver repopulation.
Chen J; Yang T; Song S; Liu Q; Sun Y; Zhao L; Fu Z; Wang MJ; Hu YP; Chen F
Biochem Biophys Res Commun; 2019 Aug; 516(2):591-598. PubMed ID: 31239154
[TBL] [Abstract][Full Text] [Related]
29. Efficient liver repopulation of transplanted hepatocyte prevents cirrhosis in a rat model of hereditary tyrosinemia type I.
Zhang L; Shao Y; Li L; Tian F; Cen J; Chen X; Hu D; Zhou Y; Xie W; Zheng Y; Ji Y; Liu M; Li D; Hui L
Sci Rep; 2016 Aug; 6():31460. PubMed ID: 27510266
[TBL] [Abstract][Full Text] [Related]
30. Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer.
Burfeind KG; Zhu X; Norgard MA; Levasseur PR; Huisman C; Buenafe AC; Olson B; Michaelis KA; Torres ER; Jeng S; McWeeney S; Raber J; Marks DL
Elife; 2020 May; 9():. PubMed ID: 32391790
[TBL] [Abstract][Full Text] [Related]
31. Hedgehog signaling pathway regulates liver regeneration in the Fah
Xu X; Jiao X; Jiao Y; Wang M; Jiao C
Int J Clin Exp Pathol; 2017; 10(9):9837-9845. PubMed ID: 31966871
[TBL] [Abstract][Full Text] [Related]
32. Ex vivo gene editing and cell therapy for hereditary tyrosinemia type 1.
Ates I; Stuart C; Rathbone T; Barzi M; He G; Major AM; Shankar V; Lyman RA; Angner SS; Mackay TFC; Srinivasan S; Farris AB; Bissig KD; Cottle RN
Hepatol Commun; 2024 May; 8(5):. PubMed ID: 38668730
[TBL] [Abstract][Full Text] [Related]
33. Multiple effects on liver-specific gene expression in albino lethal mice caused by deficiency of an enzyme in tyrosine metabolism.
Kelsey G; Ruppert S; Schedl A; Schmid E; Thies E; Schütz G
J Cell Sci Suppl; 1992; 16():117-22. PubMed ID: 1297646
[TBL] [Abstract][Full Text] [Related]
34. Intrablastocyst injection with human CD34+/CD133+ cells increase survival of immunocompetent fumarylacetoacetate hydrolase knockout mice.
Marra E; Turrini P; Tripodi M; Ciliberto G; Padron J; Aurisicchio L
Lab Anim; 2012 Oct; 46(4):280-6. PubMed ID: 23097560
[TBL] [Abstract][Full Text] [Related]
35. Analysis of corneal inflammation induced by cauterisation in CCR2 and MCP-1 knockout mice.
Oshima T; Sonoda KH; Tsutsumi-Miyahara C; Qiao H; Hisatomi T; Nakao S; Hamano S; Egashira K; Charo IF; Ishibashi T
Br J Ophthalmol; 2006 Feb; 90(2):218-22. PubMed ID: 16424537
[TBL] [Abstract][Full Text] [Related]
36. Homologous recombination mediates stable Fah gene integration and phenotypic correction in tyrosinaemia mouse-model.
Junge N; Yuan Q; Vu TH; Krooss S; Bednarski C; Balakrishnan A; Cathomen T; Manns MP; Baumann U; Sharma AD; Ott M
World J Hepatol; 2018 Feb; 10(2):277-286. PubMed ID: 29527263
[TBL] [Abstract][Full Text] [Related]
37. Dendrimer-Based Lipid Nanoparticles Deliver Therapeutic FAH mRNA to Normalize Liver Function and Extend Survival in a Mouse Model of Hepatorenal Tyrosinemia Type I.
Cheng Q; Wei T; Jia Y; Farbiak L; Zhou K; Zhang S; Wei Y; Zhu H; Siegwart DJ
Adv Mater; 2018 Dec; 30(52):e1805308. PubMed ID: 30368954
[TBL] [Abstract][Full Text] [Related]
38. D-serine-induced nephrotoxicity: possible interaction with tyrosine metabolism.
Williams RE; Lock EA
Toxicology; 2004 Sep; 201(1-3):231-8. PubMed ID: 15297036
[TBL] [Abstract][Full Text] [Related]
39. Fah Knockout Animals as Models for Therapeutic Liver Repopulation.
Grompe M
Adv Exp Med Biol; 2017; 959():215-230. PubMed ID: 28755199
[TBL] [Abstract][Full Text] [Related]
40. Long-term therapy with NTBC and tyrosine-restricted diet in a murine model of hereditary tyrosinemia type I.
Al-Dhalimy M; Overturf K; Finegold M; Grompe M
Mol Genet Metab; 2002 Jan; 75(1):38-45. PubMed ID: 11825062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
